DelveInsight’s “Psoriasis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Psoriasis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Psoriasis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Psoriasis: An Overview
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas. arthritis and mental disorders.
Although there is no cure for psoriasis, there are multiple effective treatment options, and topical therapy is the standard of care for treatment. Mild to moderate psoriasis can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy. Systemic treatment is required in moderate to severe cases.
Psoriasis Market Key Facts
-
As per the study by Mease et al., “up to 40% of patients with psoriasis go on to develop PsA, usually within 5-10 years of cutaneous disease onset”.
-
According to the National Psoriasis Foundation (NPF), approximately 8 million Americans are affected by psoriasis, resulting in a 2–4% prevalence in the United States, according to population-based estimates.
-
According to National Health and Nutrition Examination Survey, an increase in prevalence from 1.62% to 3.10% from 2004 to 2010 was observed in the United States.
-
As per a study by Parisi et al., (2020), Psoriasis can occur at any age, although most patients present with the condition before 35 years old.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Psoriasis market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Psoriasis market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Psoriasis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Psoriasis Epidemiology Segmentation
-
Prevalence of Psoriasis in Pediatrics
-
Prevalence of Psoriasis in Adults
-
Type-specific prevalent case of Psoriasis
-
Severity-specific prevalent cases of Psoriasis
-
Location-specific prevalent cases of Psoriasis
Psoriasis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriasis market or expected to get launched during the study period. The analysis covers Psoriasis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Psoriasis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Psoriasis Market Will Evolve by 2032 @ https://www.delveinsight.com/sample-request/psoriasis-market
Psoriasis Therapeutics Analysis
Several companies across the globe are thoroughly working toward the development of new treatments and devices, which are expected to change the current market scenario for Psoriasis in the coming years.
Some of the Key companies in the Psoriasis Market include:
-
UCB
-
Eli Lilly and Company
-
Boehringer Ingelheim)
-
Akros Pharma Inc.
-
Kadmon Pharmaceuticals
-
Pfizer
-
Arbor Pharmaceuticals
-
Dr. Reddy’s Laboratories
-
Dermavant
and several others.
Psoriasis Therapies covered in the report include:
-
Bimekizumab
-
Mirikizumab
-
BI 730357
-
JTE-451
-
KD025
-
PF-06826647
-
XP23829
-
Tapinarof
And many more.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More –
https://www.delveinsight.com/sample-request/psoriasis-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Psoriasis Competitive Intelligence Analysis
4. Psoriasis Market Overview at a Glance
5. Psoriasis Disease Background and Overview
6. Psoriasis Patient Journey
7. Psoriasis Epidemiology and Patient Population (In US, EU5, and Japan)
8. Psoriasis Treatment Algorithm, Current Treatment, and Medical Practices
9. Psoriasis Unmet Needs
10. Key Endpoints of Psoriasis Treatment
11. Psoriasis Marketed Products
12. Psoriasis Emerging Drugs and Latest Therapeutic Advances
13. Psoriasis Seven Major Market Analysis
14. Attribute Analysis
15. Psoriasis Market Outlook (In US, EU5, and Japan)
16. Psoriasis Access and Reimbursement Overview
17. KOL Views on the Psoriasis Market
18. Psoriasis Market Drivers
19. Psoriasis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report:
https://www.delveinsight.com/sample-request/psoriasis-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports By DelveInsight
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
“Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Chronic Inflammatory Demyelinating Polyneuropathy Market size, share, and trends in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/